Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Combination therapy may benefit MS patients

  • Comment
A combination therapy of an antibiotic and a medication used to treat multiple sclerosis may slow the progress of the disease, a study has shown.

According to a preliminary study, combining daily 100 milligram doses doxycycline and interferon therapy reduced the number of brain lesions by a quarter in a group of 15 relapsing patients.

Fewer lesions were visible using MRI scans, the study said, and patients also had reduced scores on a scale designed to assess disability.
Only one patient in the study group relapsed and adverse effects caused by the medication were mild.

The study is due to be printed in the February 2008 edition of the Archives of Neurology.
Archives of Neurology (2008) 65
  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs